High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings

Authors

  • Charanpreet Singh Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Sarthak Wadhera Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Uday Yanamandra Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Parathan Karunakaran Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Nishant Jindal Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Saloni Rani Kumar Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Neha Saini Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Aditya Jandial Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Arihant Jain Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Chandan Das Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Gaurav Prakash Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Alka Khadwal Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Shano Naseem Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Reena Das Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Neelam Varma Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Subhash Varma Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Pankaj Malhotra Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Deepesh Lad Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

DOI:

https://doi.org/10.1080/0284186X.2022.2162347

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2022-12-02

How to Cite

Singh, C., Wadhera, S., Yanamandra, U., Karunakaran, P., Jindal, N., Rani Kumar, S., … Lad, D. (2022). High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings. Acta Oncologica, 61(12), 1512–1514. https://doi.org/10.1080/0284186X.2022.2162347

Issue

Vol. 61 No. 12 (2022): Acta Oncologica

Section

Articles